The largest drug
discovery company
in the CEE region


Your integrated drug
discovery partner of choice


Developing breakthrough
therapies in oncology


Delivering comprehensive
research solutions to biotech
and pharma


News See all

Selvita Announces Shareholder Approval of Corporate Split and New…

- Both companies will be independently listed on the Warsaw Stock Exchange with formal completion of the split expected in...

Selvita Announces First Patient Dosed in Phase 1b Study…

Krakow, Poland – 06 September 2019 – Selvita (WSE: SLV) today announced that the first patient enrolled in the Phase...

Selvita Reports Second Quarter and Half-Year 2019 Financial Results

Krakow, Poland – 5 September 2019 – Selvita (WSE:SLV) today reported second quarter 2019 financial results and provided a corporate...

Polish Financial Supervision Authority Approves Selvita CRO Prospectus, Allowing…

- Shareholder meeting to be held Sept. 19, 2019, for a vote on the split, name of Ryvu Therapeutics for...

Selvita to Present at Upcoming Conferences in September

Krakow, Poland – 3 September 2019 – Selvita (WSE: SLV) today announced that Pawel Przewiezlikowski, Chief Executive Officer, will present...

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.


Drug Discovery Services

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.


Research and Development

In its internal research and development efforts, Selvita focuses on different dimensions of oncology.

The company’s most advanced R&D program is SEL24, a dual PIM/FLT3 kinase inhibitor currently in Phase I/II clinical study, in acute myeloid leukemia.


Warning: file_get_contents( failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /selvita_www/wp-content/themes/selvita/Selvita.php on line 168

Investor Relations SLV PLN ( )

Share price

PLN More


We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.